Estrogen decreases expression of chemokine receptors, and suppresses chemokine bioactivity in murine monocytes

Kelly Janis, Janice Hoeltke, Michael Nazareth, Peter Fanti, Kristin Poppenberg, Susan M. Aronica

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Problem: We propose that the ability of estrogen exposure to increase the probability of a woman developing breast cancer may be related to decreased chemokine activity and suppression of immune surveillance in mammary tissue. The present study was conducted to determine whether estrogen could decrease monocyte bioactivity through alteration of chemokine receptor expression. Method of study: We examined the effect of estrogen and tamoxifen on the expression of the chemokine receptors CCR2 and CXCR3 on murine monocytes treated in culture and in vivo. Effects of estrogen on chemokine activation of monocytes were also evaluated. Results: Estrogen and tamoxifen significantly decreased expression of CCR2 and, to a lesser extent, CXCR3 on murine monocytes. Estrogen decreased chemotaxis of monocytes towards MCP-1/JE. The chemokines MCP-1/JE and MIP-1α were unable to evoke increases in intracellular calcium in murine monocytes treated with estrogen, alone or in combination with tamoxifen. Conclusions: Our results show that estrogen suppresses the ability of monocytes to respond to certain chemokines, suggesting that estrogen exposure might decrease immune surveillance in tissues where the action of specific chemokines is involved.

Original languageEnglish (US)
Pages (from-to)22-31
Number of pages10
JournalAmerican Journal of Reproductive Immunology
Volume51
Issue number1
DOIs
StatePublished - Jan 2004
Externally publishedYes

Fingerprint

Chemokine Receptors
Chemokines
Monocytes
Estrogens
Tamoxifen
Aptitude
Chemotaxis
Breast
Breast Neoplasms
Calcium

Keywords

  • Chemokine
  • Chemokine receptor
  • Estrogen
  • Monocyte

ASJC Scopus subject areas

  • Immunology
  • Obstetrics and Gynecology

Cite this

Estrogen decreases expression of chemokine receptors, and suppresses chemokine bioactivity in murine monocytes. / Janis, Kelly; Hoeltke, Janice; Nazareth, Michael; Fanti, Peter; Poppenberg, Kristin; Aronica, Susan M.

In: American Journal of Reproductive Immunology, Vol. 51, No. 1, 01.2004, p. 22-31.

Research output: Contribution to journalArticle

Janis, Kelly ; Hoeltke, Janice ; Nazareth, Michael ; Fanti, Peter ; Poppenberg, Kristin ; Aronica, Susan M. / Estrogen decreases expression of chemokine receptors, and suppresses chemokine bioactivity in murine monocytes. In: American Journal of Reproductive Immunology. 2004 ; Vol. 51, No. 1. pp. 22-31.
@article{f7943b22dda14d7695bccb5b9d3da972,
title = "Estrogen decreases expression of chemokine receptors, and suppresses chemokine bioactivity in murine monocytes",
abstract = "Problem: We propose that the ability of estrogen exposure to increase the probability of a woman developing breast cancer may be related to decreased chemokine activity and suppression of immune surveillance in mammary tissue. The present study was conducted to determine whether estrogen could decrease monocyte bioactivity through alteration of chemokine receptor expression. Method of study: We examined the effect of estrogen and tamoxifen on the expression of the chemokine receptors CCR2 and CXCR3 on murine monocytes treated in culture and in vivo. Effects of estrogen on chemokine activation of monocytes were also evaluated. Results: Estrogen and tamoxifen significantly decreased expression of CCR2 and, to a lesser extent, CXCR3 on murine monocytes. Estrogen decreased chemotaxis of monocytes towards MCP-1/JE. The chemokines MCP-1/JE and MIP-1α were unable to evoke increases in intracellular calcium in murine monocytes treated with estrogen, alone or in combination with tamoxifen. Conclusions: Our results show that estrogen suppresses the ability of monocytes to respond to certain chemokines, suggesting that estrogen exposure might decrease immune surveillance in tissues where the action of specific chemokines is involved.",
keywords = "Chemokine, Chemokine receptor, Estrogen, Monocyte",
author = "Kelly Janis and Janice Hoeltke and Michael Nazareth and Peter Fanti and Kristin Poppenberg and Aronica, {Susan M.}",
year = "2004",
month = "1",
doi = "10.1046/j.8755-8920.2003.00117.x",
language = "English (US)",
volume = "51",
pages = "22--31",
journal = "American Journal of Reproductive Immunology and Microbiology",
issn = "1046-7408",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Estrogen decreases expression of chemokine receptors, and suppresses chemokine bioactivity in murine monocytes

AU - Janis, Kelly

AU - Hoeltke, Janice

AU - Nazareth, Michael

AU - Fanti, Peter

AU - Poppenberg, Kristin

AU - Aronica, Susan M.

PY - 2004/1

Y1 - 2004/1

N2 - Problem: We propose that the ability of estrogen exposure to increase the probability of a woman developing breast cancer may be related to decreased chemokine activity and suppression of immune surveillance in mammary tissue. The present study was conducted to determine whether estrogen could decrease monocyte bioactivity through alteration of chemokine receptor expression. Method of study: We examined the effect of estrogen and tamoxifen on the expression of the chemokine receptors CCR2 and CXCR3 on murine monocytes treated in culture and in vivo. Effects of estrogen on chemokine activation of monocytes were also evaluated. Results: Estrogen and tamoxifen significantly decreased expression of CCR2 and, to a lesser extent, CXCR3 on murine monocytes. Estrogen decreased chemotaxis of monocytes towards MCP-1/JE. The chemokines MCP-1/JE and MIP-1α were unable to evoke increases in intracellular calcium in murine monocytes treated with estrogen, alone or in combination with tamoxifen. Conclusions: Our results show that estrogen suppresses the ability of monocytes to respond to certain chemokines, suggesting that estrogen exposure might decrease immune surveillance in tissues where the action of specific chemokines is involved.

AB - Problem: We propose that the ability of estrogen exposure to increase the probability of a woman developing breast cancer may be related to decreased chemokine activity and suppression of immune surveillance in mammary tissue. The present study was conducted to determine whether estrogen could decrease monocyte bioactivity through alteration of chemokine receptor expression. Method of study: We examined the effect of estrogen and tamoxifen on the expression of the chemokine receptors CCR2 and CXCR3 on murine monocytes treated in culture and in vivo. Effects of estrogen on chemokine activation of monocytes were also evaluated. Results: Estrogen and tamoxifen significantly decreased expression of CCR2 and, to a lesser extent, CXCR3 on murine monocytes. Estrogen decreased chemotaxis of monocytes towards MCP-1/JE. The chemokines MCP-1/JE and MIP-1α were unable to evoke increases in intracellular calcium in murine monocytes treated with estrogen, alone or in combination with tamoxifen. Conclusions: Our results show that estrogen suppresses the ability of monocytes to respond to certain chemokines, suggesting that estrogen exposure might decrease immune surveillance in tissues where the action of specific chemokines is involved.

KW - Chemokine

KW - Chemokine receptor

KW - Estrogen

KW - Monocyte

UR - http://www.scopus.com/inward/record.url?scp=0442325394&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0442325394&partnerID=8YFLogxK

U2 - 10.1046/j.8755-8920.2003.00117.x

DO - 10.1046/j.8755-8920.2003.00117.x

M3 - Article

C2 - 14725563

AN - SCOPUS:0442325394

VL - 51

SP - 22

EP - 31

JO - American Journal of Reproductive Immunology and Microbiology

JF - American Journal of Reproductive Immunology and Microbiology

SN - 1046-7408

IS - 1

ER -